Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
121696052 | 12169605 | 2 | F | 20160706 | 20160310 | 20160712 | EXP | CA-ABBVIE-16P-028-1579284-00 | ABBVIE | RIZEK P, IKEDA K, MELE T, ET AL. BOWEL ISCHEMIA IN REFRACTORY STATUS EPILEPTICUS. NEUROCRIT CARE. 2016;24(1):128-131. | 21.00 | YR | M | Y | 0.00000 | 20160712 | OT | COUNTRY NOT SPECIFIED | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
121696052 | 12169605 | 1 | PS | VALPROIC ACID. | VALPROIC ACID | 1 | Unknown | U | UNKNOWN | 18081 | SYRUP | ||||||||
121696052 | 12169605 | 2 | SS | VALPROIC ACID. | VALPROIC ACID | 1 | Unknown | U | UNKNOWN | 18081 | TABLET | ||||||||
121696052 | 12169605 | 3 | SS | ISOFLURANE. | ISOFLURANE | 1 | Respiratory (inhalation) | U | UNKNOWN | 0 | |||||||||
121696052 | 12169605 | 4 | SS | MIDAZOLAM | MIDAZOLAMMIDAZOLAM HYDROCHLORIDE | 1 | Intramuscular | U | UNKNOWN | 0 | |||||||||
121696052 | 12169605 | 5 | SS | PHENYTOIN. | PHENYTOIN | 1 | Unknown | U | UNKNOWN | 0 | |||||||||
121696052 | 12169605 | 6 | SS | LEVETIRACETAM. | LEVETIRACETAM | 1 | Unknown | U | UNKNOWN | 0 | TABLET | ||||||||
121696052 | 12169605 | 7 | SS | PHENOBARBITAL. | PHENOBARBITAL | 1 | Intravenous (not otherwise specified) | U | UNKNOWN | 0 | 100 | MG | Q12H | ||||||
121696052 | 12169605 | 8 | SS | LACOSAMIDE. | LACOSAMIDE | 1 | Unknown | U | UNKNOWN | 0 | |||||||||
121696052 | 12169605 | 9 | SS | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Intravenous (not otherwise specified) | U | UNKNOWN | 0 | |||||||||
121696052 | 12169605 | 10 | SS | PROPOFOL. | PROPOFOL | 1 | Unknown | U | UNKNOWN | 0 | EMULSION FOR INJECTION | ||||||||
121696052 | 12169605 | 11 | C | IMMUNOGLOBULIN | HUMAN IMMUNOGLOBULIN G | 1 | Intravenous (not otherwise specified) | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
121696052 | 12169605 | 1 | Seizure |
121696052 | 12169605 | 3 | Seizure |
121696052 | 12169605 | 4 | Seizure |
121696052 | 12169605 | 5 | Seizure |
121696052 | 12169605 | 6 | Seizure |
121696052 | 12169605 | 7 | Seizure |
121696052 | 12169605 | 8 | Seizure |
121696052 | 12169605 | 9 | Product used for unknown indication |
121696052 | 12169605 | 10 | Seizure |
121696052 | 12169605 | 11 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
121696052 | 12169605 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
121696052 | 12169605 | Abdominal distension | |
121696052 | 12169605 | Blood lactic acid increased | |
121696052 | 12169605 | Drug ineffective | |
121696052 | 12169605 | Heart rate increased | |
121696052 | 12169605 | Hypotension | |
121696052 | 12169605 | Ileus | |
121696052 | 12169605 | Intestinal ischaemia | |
121696052 | 12169605 | Leukocytosis | |
121696052 | 12169605 | Mucosal ulceration | |
121696052 | 12169605 | Necrosis ischaemic | |
121696052 | 12169605 | Pyrexia | |
121696052 | 12169605 | Superinfection | |
121696052 | 12169605 | Systemic inflammatory response syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |